NND Rapid Test Panel (Urine), Detection of N, N-Dimethyltryptamine in urine, DOA TEST
Brand Name:Citest
Certification:CE
Model Number:DNND-114
Minimum Order Quantity:N/A
Place of Origin:-
Price:negotiation
Contact Now
Add to Cart
Verified Supplier
Location:
Hangzhou Zhejiang
Address:
170-422, Richards Street, Vancouver BC V6B 2Z4, CANADA
Supplier`s last login times:
within 28 hours
Product Details
Company Profile
Product Details
NND Rapid Test Panel (Urine), Detection of N, N-Dimethyltryptamine in urine, DOA TEST
| Product: | NND Rapid Test Cassette, Detection Of N, N-Dimethyltryptamine In Urine,Drug Abuse Test Kit |
| Certificate: | CE |
| Principle: | Chromatographic Immunoassay |
| Reading Time: | 5 Minutes |
| Storage Temperature: | 2-30°C |
| Sensitivity: | 96.70% |
| Accuracy: | 96.90% |
| Cat. No.: | DNND-114 |
| Format: | Dipstick, Cassette, Panel |
| Specimen: | Urine |
| Pack: | 40T |
| Shelf Life: | 2 Years |
| Specificity: | 97.00% |
| Cut-Off: | 500 Ng/mL |
A rapid test for the qualitative detection of N,
N-Dimethyltryptamine in human urine. For professional in vitro diagnostic use only.
INTENDED USE
The NND Rapid Test Panel (Urine) is a rapid chromatographic
immunoassay for the detection of N, N-Dimethyltryptamine in urine at a cut-off
concentration of 1000 ng/mL. This test will detect other related compounds, please refer to the
Analytical Specificity table in this package insert.
This assay provides only a qualitative, preliminary analytical test
result. A more specific alternate chemical method must be used in order to obtain
a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) is
the preferred confirmatory method. Clinical consideration and professional
judgment should be applied to any drug of abuse test result, particularly when
preliminary positive results are used.
SUMMARY
N, N-Dimethyltryptamine is a powerful and illegal hallucinogenic
drug. While there is an open debate on whether or not N, N-Dimethyltryptamine is
addictive, this drug poses dangerous physical and psychological effects for frequent
users. Additionally,
individuals who frequently abuse N, N-Dimethyltryptamine often
develop a dependence on the drug, proving the dangers of N,
N-Dimethyltryptamine abuse.
N, N-Dimethyltryptamine produces a high referred to as a
psychedelic trip. When smoked, a N, N-Dimethyltryptamine trip usually begins instantly and lasts less
than an hour. However, when drunk in the form of Ayahuasca tea, hallucinations
begin after about 30 minutes and may last from 4-6 hours. Some users report
experiencing mild, lingering hallucinogenic effects for several days after consuming
or smoking N, N-Dimethyltryptamine.
On a physiological level, N, N-Dimethyltryptamine causes an array of adverse side effects.The NND Rapid Test Panel (Urine) is a rapid urine-screening test
that can be performed without the use of an instrument. The test utilizes the
antibody to selectively
detect elevated levels of N, N-Dimethyltryptamine in urine. The NND
Rapid Test Panel (Urine) yields a positive result when the N, N-Dimethyltryptamine
in urine exceed the cut-off level.
PRINCIPLE
The NND Rapid Test Panel (Urine) is an immunoassay based on the
principle of competitive binding. Drugs which may be present in the urine
specimen compete against the drug conjugate for binding sites on the antibody.
During testing, a urine specimen migrates upward by capillary
action. N, N-Dimethyltryptamine , if present in the urine specimen below
the cut-off level, will not saturate the binding sites of the antibody in the test. The
antibody coated particles will then be captured by immobilized N,
N-Dimethyltryptamine-protein conjugate and a visible colored line will show up in the test line region. The
colored line will not form in the test line region if the N, N-Dimethyltryptamine level exceeds
the cut-off level, because it will saturate all the binding sites of anti-N,
N-Dimethyltryptamine antibody.
A drug-positive urine specimen will not generate a colored line in
the test line region because of drug competition, while a drug-negative urine specimen
or a specimen containing a drug concentration less than the cut-off will generate
a line in the test line
region. To serve as a procedural control, a colored line will
always appear at the control line region indicating that proper volume of specimen has
been added and membrane wicking has occurred.
DIRECTIONS FOR USE
Allow the test, urine specimen, and/or controls to reach room
temperature (15-30 °C) prior to testing.
1. Remove the test panel from the sealed pouch and use it as soon
as possible.
2. Remove the cap.
3. With the arrow pointing toward the urine specimen, immerse the
test panel vertically in the urine specimen for at least 10 to 15 seconds. Immerse the strip to at least the level of the wavy lines, but do not touch the plastic device.
4. Replace the cap and place the test panel on a non-absorbent flat
surface.
5. Start the timer and wait for the colored line(s) to appear.
6. Read results at 5 minutes. Do not interpret the result after 10 minutes.
INTERPRETATION OF RESULTS
(Please refer to the illustration above)
NEGATIVE:* Two colored lines appear. One colored line should be in the control line region (C), and another apparent colored line should be in the test
line region (T). This negative result indicates that the N, N-Dimethyltryptamine
concentration is below the detectable cut-off level.
*NOTE: The shade of color in the test line region (T) may vary, but it
should be considered negative whenever there is even a faint colored line.
POSITIVE: One colored line appears in the control line region (C). No line appears in the test line region (T). This positive result indicates that
the N, N-Dimethyltryptamine concentration exceeds the detectable cut-off level.
INVALID: Control line fails to appear. Insufficient specimen volume or incorrect procedural techniques are the most likely reasons for control line
failure. Review the procedure and repeat the test with a new test. If the problem
persists, discontinue using the test kit immediately and contact local distributor.
QUALITY CONTROL
A procedural control is included in the test. A colored line
appearing in the control line region (C) is considered an internal procedural control. It
confirms sufficient specimen volume, adequate membrane wicking and correct procedural technique. Control standards are not supplied with this kit; however, it is
recommended that positive and negative controls be tested as good laboratory testing
practice to confirm the test procedure and to verify proper test performance.
ORDER INFORMATION
| DNND-102 | NND Rapid Test Cassette | Urine | 40T | 500 ng/mL |
| DNND-114 | NND Rapid Test Panel | Urine | 40T | 500 ng/mL |
| DNND-101/111 | NND Rapid Test Dipstick | Urine | 50T | 500 ng/mL |
NND Rapid Test Panel (Urine), Detection of N, N-Dimethyltryptamine in urine, DOA TEST
Inquiry Cart
0